Combining flavin photocatalysis with parallel synthesis: a general platform to optimize peptides with non-proteinogenic amino acids
View/ Open
Issue Date
2021-06-30Author
Immel, Jacob R.
Chilamari, Maheshwerreddy
Bloom, Steven
Publisher
Royal Society of Chemistry
Type
Article
Article Version
Scholarly/refereed, publisher version
Rights
© 2021 The Author(s). Published by the Royal Society of Chemistry. This work is licensed under a Creative Commons Attribution 4.0 International License.
Metadata
Show full item recordAbstract
Most peptide drugs contain non-proteinogenic amino acids (NPAAs), born out through extensive structure–activity relationship (SAR) studies using solid-phase peptide synthesis (SPPS). Synthetically laborious and expensive to manufacture, NPAAs also can have poor coupling efficiencies allowing only a small fraction to be sampled by conventional SPPS. To gain general access to NPAA-containing peptides, we developed a first-generation platform that merges contemporary flavin photocatalysis with parallel synthesis to simultaneously make, purify, quantify, and even test up to 96 single-NPAA peptide variants via the unique combination of boronic acids and a dehydroalanine residue in a peptide. We showcase the power of our newly minted platform to introduce NPAAs of diverse chemotypes-aliphatic, aromatic, heteroaromatic-directly into peptides, including 15 entirely new residues, and to evolve a simple proteinogenic peptide into an unnatural inhibitor of thrombin by non-classical peptide SAR.
Collections
Citation
Immel, J. R., Chilamari, M., & Bloom, S. (2021). Combining flavin photocatalysis with parallel synthesis: a general platform to optimize peptides with non-proteinogenic amino acids. Chemical science, 12(29), 10083–10091. https://doi.org/10.1039/d1sc02562g
Items in KU ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
We want to hear from you! Please share your stories about how Open Access to this item benefits YOU.